Complement activation on human neuroblastoma cell lines in vitro: Route of activation and expression of functional complement regulatory proteins

Journal of Neuroimmunology

Volumn 66, Issue 1-2, 1996, Pages 29-40

  Gasque, Philippe ^a   Thomas, Anne ^b   Fontaine, Marc ^b   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Inst Natl de la Sante/de la R M   (France)

Author keywords

classical pathway; complement; neurodegeneration; neurons; regulatory proteins

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C1S INHIBITOR; CYTOKINE; DEXAMETHASONE; PHORBOL ESTER; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0029896853     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00015-X     Document Type: Article

References (41)

1. Avery, V.M., Adrian, D.L. and Gordon, D.L. (1993) Detection of mosaic protein mRNA in human astrocytes. Immunol. Cell Biol. 71, 215-219.
2. Barnum, S.R. (1995) Complement biosynthesis in the central nervous system. Critical Reviews in Oral Biology and Medicine, Vol. 6, pp. 132-146.
3. Colten, H.R. (1994) Drawing a double-edged sword. Nature 371, 474.
4. Compston, D.A.S., Morgan, B.P., Campbell, A.K., Wilkins, P., Cole, G., Thomas, N.D. and Jasani, B. (1989) Immunocytoehemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15, 307-316.
5. Eikelenboom, P., Fraser, H., Rozemuller, J.M. and Stam, F.C. (1988) The blood-brain barrier in cerebral amyloidogenesis in Alzheimer's disease and scrapie. In: A. Pouplard-Barthelaix, J. Emile and Y. Christen (Eds.), Immunology and Alzheimer's Disease, Springer-Verlag, Berlin, pp. 30-41.
6. Eikelenboom, P., Hack, C.E., Rozemuller, J.M., and Stam, F.C. (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B Cell Pathol. 56, 259-262.
7. Gasque, P., Julen, N., Ischenko, A.M., Picot, C., Mauger, C., Chauzy, C., Ripoche, J. and Fontaine, M. (1992) Expression of complement of the alternative pathway by glioma cell lines. J. Immunol. 149, 1381-1387.
8. Gasque, P., Ischenko, A.M., Legoedec, J., Mauger, C., Schouft, M.T. and Fontaine, M. (1993) Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem. 268, 25068-25074.
9. Gasque, P., Fontaine, M. and Morgan, B.P. (1995) Complement expression in human brain: Biosynthesis of the terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154, 4726-4733.
10. Gay, D. and Esiri, M. (1991) Blood-brain barrier damage in acute multiple sclerosis plaques: an immunohistochemical study. Brain 114, 557-572.
11. Gordon, D.L., Avery, V.M., Adrian, D.L. and Sadlon, T.A. (1992) Detection of complement protein mRNA in human astrocytes by polymerase chain reaction. J. Neurosci. Meth. 45, 191-197.
12. Haga, S., Ikeda, K., Sato, M. and Ishii, T. (1993) Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601, 88-94.
13. Ishii, T. and Haga, S. (1984) Immuno-electron microscopic localisation of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 63, 296-300.
14. Jiang, H., Burdick, D., Glabe, C.G., Cotman, C.W. and Tenner, A.J. (1994) Beta amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152, 5050-5059.
15. Johnson, S.A., Lampert Etchells, M., Pasinetti, G.M., Rozovsky, I. and Finch, C.E. (1992) Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. of aging, 13, 641-648.
16. Levi-Strauss, M. and Mallat, M. (1987) Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol. 139, 2361-2366.
17. Linington, C., Morgan, B.P., Scolding, N.J., Wilkins, P., Piddlesden, S. and Compston, D.A.S. (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112, 895-911.
18. Liszewski, M.K., Post, T.W. and Atkinson, J.P. (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Ann. Rev. Immunol. 9, 431-455.
19. Lue, L.-F. and Rogers, J. (1992) Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum. Dementia 3, 308-313.
20. McGeer, P.L., Akiyama, H., Itagaki. S. and McGeer, E.G. (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107, 341-346.
21. Meri, S., Waldmann, H. and Lachmann, PJ. (1991) Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab. Invest. 65, 532-537.
22. Morgan, B.P. (1992) Isolation and characterisation of the complement inhibiting protein CD59 antigen from platelet membranes. Biochem. J. 282, 209-213.
23. Morgan, B.P. (1993) Complement in diseases of the nervous system. In: K. Whaley, M. Loos and J.M. Weiler (Eds.), Complement in health and disease, Kluwer, Dordrecht, Boston and London, pp. 353-375.
24. Morgan, B.P. (1994) Clinical complementology: Recent progress and future trends. Eur. J. Clin. Invest. 24, 219-228.
25. Morgan, B.P. (1995) Physiology and pathology of complement: Progress and trends. Crit. Rev. Clin. Lab. Sei. 32, 265-298.
26. Nose, M., Katoh, M., Okada, N., Kyogoku, M. and Okada, H. (1990) Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology. 70, 145-149.
27. Pasinetti, G.M., Johnson, S.A., Rozovsky, I., Lampert-Etchells, M., Morgan, D.G., Gordon, M.N., Morgan, T.E., Willoughby, D. and Finch, C.E. (1992) Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118, 117-125.
28. Piddlesden, S.J. and Morgan, B.P. (1993) Killing of rat glial cells by complement: Deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48, 169-176.
29. Piddlesden, S.J., Storch, M.K., Hibbs, M., Freeman, A.M., Lassmann, H. and Morgan, B.P. (1994) Soluble complement receptor 1 (sCR1) inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152, 5477-5484.
30. Rogers, J., Cooper, N.R., Webster, S., Schultz, J., McGeer, P.L., Styren, S.D., Civin, W.H., Brachova, L., Bradt, B., Ward, P. and Lieberburg, I. (1992) Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
31. Rus, H.G., Kim, L.M., Niculescu, F.I. and Shin, M.L. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and newcastle disease virus. J. Neuroimmunol. 148, 928-933.
32. Scolding, N.J., Morgan, B.P., Houston, W.A., Linington, C., Campbell, A.K. and Compston, D.A.S. (1989) Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339, 620-622.
33. Shibata, T., Cosio, F.G. and Birminham, D.J. (1991) Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J. Immunol. 147, 3901-3908.
34. Shibata, T. and Kohsaka, T. (1995) Effects of complement activation on the expression of CD59 by human mesangial cells. J. Immunol. 155, 403-409.
35. Svensson, M. and Aldskogius, H. (1992) Evidence for activation of the complement cascade in the hypoglossal nucleus following peripheral nerve injury. J. Neuroimmunol. 40, 99-110.
36. Vedeler, C., Ulvestad, E., Bjorge, L., Conti, G., Williams, K., Mork, S. and Matre, R. (1994) The expression of CD59 in normal human nervous tissue. Immunology 82, 542-547.
37. Veerhuis, R., Janssen, I., Hack, C.E. and Eikelenboom, P. (1996) Early complement components in Alzheimer's disease brains. Acta Neuropathol. 91, 53-60.
38. Walker, D.G. and McGeer, P.L. (1992) Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14, 109-116.
39. Walker, D.G. and McGeer, P.L. (1993) Complement gene expression in neuroblastoma and astrocytoma cell lines of human origin. Neurosci. Lett. 157, 99-102.
40. Yasuhara, O., Matsuo, A., Tooyama, I., Kimura, H., McGeer, E. and McGeer, P.L. (1995) Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons. Acta Neuropathol. 89, 322-330.
41. Zajicek, J., Wing, M., Skepper, J. and Compston, D.A.S. (1995) Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Lab. Invest. 73, 128-138.